Aridis Pharmaceuticals, Inc.

Grantee website Los Gatos, California, United States

Purpose

to develop ultra-low-cost inhaled antibodies that can be readily deployed at large scale to prevent the spread of infectious pathogens in LMIC's

Division

Global Health

Date

OCTOBER 2021

Region served

GLOBAL

Committed amount

$1,933,850

Grant topic

Create Novel Technology Platform Capabilities

Duration (months)

16

Grantee location

Los Gatos, California, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.